Stock Split History
ETFs Holding SYBX »    SYBX Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Synlogic is a biopharmaceutical company focused on improving its drug discovery and development platform for Synthetic Biotic™ medicines, which are designed using synthetic biology to genetically reprogram beneficial microbes to treat metabolic and inflammatory diseases and cancer. Co.'s therapeutics programs include: SYNB1020, which is an oral therapy for the treatment of hyperammonemia, including patients with liver disease such as hepatic encephalopathy and patients with urea cycle disorders; and SYNB1618, which is an oral therapy for the treatment of phenylketonuria, a metabolic disease in which the amino acid phenylalanine accumulates in the body as a result of genetic defects. According to our Synlogic stock split history records, Synlogic has had 1 split.
Synlogic stock split history picture
Synlogic (SYBX) has 1 split in our Synlogic stock split history database. The split for SYBX took place on August 28, 2017. This was a 1 for 7 reverse split, meaning for each 7 shares of SYBX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 142.857142857143 share position following the split.

When a company such as Synlogic conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the Synlogic stock split history from start to finish, an original position size of 1000 shares would have turned into 142.857142857143 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Synlogic shares, starting with a $10,000 purchase of SYBX, presented on a split-history-adjusted basis factoring in the complete Synlogic stock split history. Synlogic split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/30/2015
End date: 10/22/2019
Start price/share: $49.00
End price/share: $2.19
Dividends collected/share: $0.00
Total return: -95.53%
Average Annual Total Return: -53.46%
Starting investment: $10,000.00
Ending investment: $447.07
Years: 4.06
Date Ratio
08/28/20171 for 7
SYBX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

SYK Split History
SYN Split History
TARO Split History
TBRA Split History
TEAR Split History
TECH Split History
TELK Split History
TENX Split History
TEVA Split History
TFX Split History

Also explore: SYBX shares outstanding history

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3X Shares (GUSH)
Kingold Jewelry, Inc. (KGJI)
Aethlon Medical, Inc. (AEMD)
Aberdeen Standard Physical Gold Shares ETF (SGOL)
Safe-T Group Ltd. (SFET)
NanoViricides, Inc. (NNVC)
Penns Woods Bancorp, Inc. (PWOD)
MoSys, Inc. (MOSY)
TOP Ships Inc. (TOPS)
Interlapse Technologies Corp. (INLA.CA)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Synlogic

Synlogic Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.